BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1610 related articles for article (PubMed ID: 25473159)

  • 1. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet effects in gut microbiome and obesity.
    Chen J; He X; Huang J
    J Food Sci; 2014 Apr; 79(4):R442-51. PubMed ID: 24621052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiota, obesity and insulin resistance.
    Shen J; Obin MS; Zhao L
    Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gut microbiota, responsible for our body weight?].
    Pataky Z; Bobbioni-Harsch E; Hadengue A; Carpentier A; Golay A
    Rev Med Suisse; 2009 Mar; 5(196):662-4, 666. PubMed ID: 19462608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota and diabetes: an evolving relationship.
    Tilg H; Moschen AR
    Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic syndrome and intestinal microflora: what overall?].
    Plotnikova EIu; Krasnov OA
    Eksp Klin Gastroenterol; 2014; (12):64-73. PubMed ID: 26058115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota and obesity.
    Blaut M; Klaus S
    Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reshaping the gut microbiota at an early age: functional impact on obesity risk?
    Luoto R; Collado MC; Salminen S; Isolauri E
    Ann Nutr Metab; 2013; 63 Suppl 2():17-26. PubMed ID: 24217033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota in obesity and metabolic disorders.
    Sanz Y; Santacruz A; Gauffin P
    Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: diet or supplementation for metabolic syndrome prevention?
    Peluso I; Romanelli L; Palmery M
    Int J Food Sci Nutr; 2014 May; 65(3):259-67. PubMed ID: 24467635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional modulation of gut microbiota - the impact on metabolic disease pathophysiology.
    Ojeda P; Bobe A; Dolan K; Leone V; Martinez K
    J Nutr Biochem; 2016 Feb; 28():191-200. PubMed ID: 26372091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and liver diseases.
    Minemura M; Shimizu Y
    World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.